Barclays’s Clorox CLX Stock Holding History

Barclays’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$3.02M	–	5098
2025 Q4	$3.02M	Buy	+30,000	New	+$3.26M	﹤0.01%	2634
2024 Q2	–	Sell	-50,000	Closed	-$7.66M	–	4928
2024 Q1	$7.66M	Hold	50,000	–	–	﹤0.01%	1574
2023 Q4	$7.13M	Sell	50,000 -440,000	-90%	-$58.7M	﹤0.01%	1804
2023 Q3	$64.2M	Buy	+490,000	New	+$74.5M	0.04%	412
2022 Q1	–	Sell	-25,800	Closed	-$4.5M	–	5023
2021 Q4	$4.5M	Hold	25,800	–	–	﹤0.01%	1786
2021 Q3	$4.27M	Sell	25,800 -10,600	-29%	-$1.83M	﹤0.01%	1736
2021 Q2	$6.55M	Hold	36,400	–	–	﹤0.01%	1434
2021 Q1	$7.02M	Buy	36,400 +27,000	+287%	+$5.2M	﹤0.01%	1256
2020 Q4	$1.9M	Hold	9,400	–	–	﹤0.01%	2268
2020 Q3	$1.98M	Hold	9,400	–	–	﹤0.01%	2117
2020 Q2	$2.06M	Sell	9,400 -41,500	-82%	-$8.29M	﹤0.01%	2097
2020 Q1	$8.82M	Buy	50,900 +23,400	+85%	+$3.87M	0.01%	1067
2019 Q4	$4.22M	Sell	27,500 -20,000	-42%	-$2.99M	﹤0.01%	2193
2019 Q3	$7.21M	Buy	47,500 +17,500	+58%	+$2.77M	﹤0.01%	1559
2019 Q2	$4.59M	Buy	30,000 +19,000	+173%	+$2.9M	﹤0.01%	1943
2019 Q1	$1.76M	Sell	11,000 -38,300	-78%	-$5.94M	﹤0.01%	2713
2018 Q4	$7.6M	Buy	49,300 +44,700	+972%	+$6.96M	0.01%	1320
2018 Q3	$692K	Sell	4,600 -24,100	-84%	-$3.42M	﹤0.01%	3992
2018 Q2	$3.88M	Buy	28,700 +3,200	+13%	+$395K	﹤0.01%	1939
2018 Q1	$3.39M	Sell	25,500 -18,200	-42%	-$2.44M	﹤0.01%	1941
2017 Q4	$6.5M	Sell	43,700 -11,600	-21%	-$1.58M	0.01%	1465
2017 Q3	$7.29M	Buy	55,300 +50,800	+1,129%	+$6.83M	0.01%	1257
2017 Q2	$600K	Sell	4,500 -19,500	-81%	-$2.63M	﹤0.01%	3345
2017 Q1	$3.24M	Sell	24,000 -3,100	-11%	-$402K	﹤0.01%	1654
2016 Q4	$3.25M	Buy	27,100 +4,400	+19%	+$519K	﹤0.01%	1712
2016 Q3	$2.84M	Buy	22,700 +19,400	+588%	+$2.54M	﹤0.01%	1714
2016 Q2	$457K	Sell	3,300 -1,700	-34%	-$220K	﹤0.01%	3286
2016 Q1	$630K	Sell	5,000 -9,200	-65%	-$1.17M	﹤0.01%	2939
2015 Q4	$1.79M	Sell	14,200 -10,100	-42%	-$1.25M	﹤0.01%	2104
2015 Q3	$2.79M	Buy	24,300 +9,000	+59%	+$1.01M	﹤0.01%	1833
2015 Q2	$1.59M	Sell	15,300 -4,600	-23%	-$496K	﹤0.01%	2440
2015 Q1	$2.19M	Sell	19,900 -5,000	-20%	-$543K	﹤0.01%	2230
2014 Q4	$2.59M	Buy	24,900 +7,700	+45%	+$770K	﹤0.01%	2293
2014 Q3	$1.65M	Sell	17,200 -10,300	-37%	-$931K	﹤0.01%	2850
2014 Q2	$2.5M	Sell	27,500 -12,900	-32%	-$1.16M	﹤0.01%	2374
2014 Q1	$3.56M	Buy	40,400 +10,300	+34%	+$904K	﹤0.01%	2000
2013 Q4	$2.77M	Sell	30,100 -70,900	-70%	-$6.39M	﹤0.01%	2342
2013 Q3	$8.18M	Buy	101,000 +16,600	+20%	+$1.4M	0.01%	1301
2013 Q2	$7.02M	Buy	+84,400	New	+$7.26M	0.01%	1354

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Barclays's CLX Position: Q1 2026 in Review

Barclays increased its Clorox (CLX) stake by 16% in Q1 2026, buying an estimated $5.34M and bringing the position to 345,801 shares worth $35.8M. The position accounts for 0.01% of the portfolio, ranked #850.

Barclays first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q2 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Barclays held 345,801 shares of Clorox worth $35.8M as of Q1 2026.
Barclays bought 47,083 Clorox shares in Q1 2026, an estimated $5.34M.
Clorox made up 0.01% of Barclays's portfolio in Q1 2026, its #850 holding.
Barclays first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
Barclays's Clorox position peaked at $122M in Q2 2024.
1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.